secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001213900-22-070825
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq notice on Nov 9, 2022, confirming compliance with $1.00 minimum bid price rule.
- Closing bid price at or above $1.00 for 10 consecutive business days (Oct 26 – Nov 8, 2022).
- Previously notified of deficiency on Dec 30, 2021; now delisting risk is eliminated.
- Compliance regained under Nasdaq Listing Rule 5550(a)(2); matter is closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022070825/0001213900-22-070825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022070825/ea168347-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-070825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer